💊
İlaç Sektörü Hisseleri
İlaç Sektörü altında 513 Hisse Senedi
İlaç sektöründe faaliyet gösteren ABD şirketlerinin hisse senetleri. Gerçek zamanlı fiyatlar, finansal analizler ve detaylı şirket bilgileri.
100
Toplam Hisse
$3.3T
Toplam Piyasa Değeri
İlaç Sektörü Hisseleri
Sayfa 1/6 (Toplam: 513)
| SEMBOL | ŞİRKET | PİYASA DEĞERİ | FİYAT | DEĞİŞİM |
|---|---|---|---|---|
| LLY | Eli Lilly and Company | $722.35B | $762.18 | 1.23% |
| JNJ | Johnson & Johnson | $395.46B | $164.36 | 0.40% |
| ABBV | AbbVie Inc. | $326.52B | $184.85 | 2.33% |
| MRK | Merck & Co., Inc. | $199.15B | $79.31 | 0.81% |
| AMGN | Amgen Inc. | $159.09B | $295.87 | 0.38% |
| TMO | Thermo Fisher Scientific Inc. | $152.86B | $404.94 | 2.37% |
| PFE | Pfizer Inc. | $137.93B | $24.26 | 0.86% |
| GILD | Gilead Sciences, Inc. | $134.69B | $108.28 | 0.06% |
| VRTX | Vertex Pharmaceuticals Incorporated | $117.74B | $458.49 | 0.29% |
| BMY | Bristol-Myers Squibb Company | $95.02B | $46.69 | 1.41% |
| MCK | McKesson Corporation | $88.83B | $711.21 | 0.20% |
| CVS | CVS Health Corporation | $77.98B | $61.64 | 0.52% |
| ZTS | Zoetis Inc. | $65.61B | $147.37 | 0.83% |
| REGN | Regeneron Pharmaceuticals, Inc. | $57.91B | $545.53 | 0.55% |
| VEEV | Veeva Systems Inc. | $45.92B | $281.00 | 0.46% |
| ALNY | Alnylam Pharmaceuticals, Inc. | $41.79B | $320.52 | 0.00% |
| CAH | Cardinal Health, Inc. | $37.85B | $158.58 | 0.61% |
| STE | STERIS plc | $21.90B | $222.65 | 1.30% |
| INSM | Insmed Incorporated | $19.52B | $102.78 | 0.22% |
| BIIB | Biogen Inc. | $17.98B | $122.68 | 1.85% |
| WST | West Pharmaceutical Services, Inc. | $15.09B | $210.08 | 0.38% |
| BAX | Baxter International Inc. | $14.05B | $27.37 | 1.44% |
| UTHR | United Therapeutics Corporation | $13.22B | $293.12 | 0.38% |
| NBIX | Neurocrine Biosciences, Inc. | $13.05B | $131.83 | 0.14% |
| INCY | Incyte Corporation | $13.04B | $67.38 | 0.71% |
| EXEL | Exelixis, Inc. | $12.07B | $44.26 | 0.47% |
| MRNA | Moderna, Inc. | $11.98B | $30.97 | 0.93% |
| BMRN | BioMarin Pharmaceutical Inc. | $10.85B | $56.56 | 1.27% |
| VTRS | Viatris Inc. | $10.45B | $8.90 | 0.23% |
| HIMS | Hims & Hers Health, Inc. | $10.26B | $47.60 | 5.52% |
| WBA | Walgreens Boots Alliance, Inc. | $9.97B | $11.52 | 0.26% |
| MEDP | Medpace Holdings, Inc. | $8.88B | $308.88 | 0.96% |
| BBIO | BridgeBio Pharma, Inc. | $8.72B | $45.90 | 1.31% |
| BPMC | Blueprint Medicines Corporation | $8.36B | $129.46 | 0.14% |
| CORT | Corcept Therapeutics Incorporated | $7.44B | $70.12 | 1.04% |
| MDGL | Madrigal Pharmaceuticals, Inc. | $7.35B | $330.94 | 0.95% |
| ELAN | Elanco Animal Health Incorporated | $7.29B | $14.68 | 0.68% |
| RVMD | Revolution Medicines, Inc. | $7.16B | $38.42 | 0.31% |
| HALO | Halozyme Therapeutics, Inc. | $6.89B | $55.92 | 0.94% |
| IONS | Ionis Pharmaceuticals, Inc. | $6.61B | $41.55 | 0.50% |
| RGEN | Repligen Corporation | $6.45B | $114.80 | 1.25% |
| TGTX | TG Therapeutics, Inc. | $5.94B | $37.42 | 1.29% |
| NUVL | Nuvalent, Inc. | $5.92B | $82.46 | 1.13% |
| RYTM | Rhythm Pharmaceuticals, Inc. | $5.64B | $88.63 | 0.64% |
| GKOS | Glaukos Corporation | $5.53B | $96.73 | 0.99% |
| AXSM | Axsome Therapeutics, Inc. | $5.40B | $109.68 | 1.81% |
| LNTH | Lantheus Holdings, Inc. | $4.95B | $71.56 | 1.97% |
| OPCH | Option Care Health, Inc. | $4.78B | $29.17 | 1.05% |
| PCVX | Vaxcyte, Inc. | $4.60B | $35.64 | 1.57% |
| CYTK | Cytokinetics, Incorporated | $4.41B | $36.96 | 0.73% |
| SLNO | Soleno Therapeutics, Inc. | $4.38B | $86.97 | 0.26% |
| KRYS | Krystal Biotech, Inc. | $4.28B | $148.09 | 0.41% |
| RNA | Avidity Biosciences, Inc. | $4.10B | $34.02 | 0.77% |
| AKRO | Akero Therapeutics, Inc. | $4.10B | $51.38 | 1.34% |
| ADMA | ADMA Biologics, Inc. | $4.09B | $17.13 | 2.39% |
| SRRK | Scholar Rock Holding Corporation | $3.90B | $41.12 | 0.98% |
| LEGN | Legend Biotech Corporation | $3.89B | $42.23 | 1.54% |
| ACLX | Arcellx, Inc. | $3.82B | $69.39 | 2.67% |
| PTCT | PTC Therapeutics, Inc. | $3.79B | $47.86 | 0.48% |
| ACAD | ACADIA Pharmaceuticals Inc. | $3.73B | $22.28 | 1.24% |
| PBH | Prestige Consumer Healthcare Inc. | $3.72B | $75.56 | 0.28% |
| AMRX | Amneal Pharmaceuticals, Inc. | $3.68B | $7.91 | 0.75% |
| VKTX | Viking Therapeutics, Inc. | $3.59B | $31.94 | 0.22% |
| SWTX | SpringWorks Therapeutics, Inc. | $3.54B | $46.99 | 0.02% |
| PTGX | Protagonist Therapeutics, Inc. | $3.42B | $55.22 | 0.47% |
| KYMR | Kymera Therapeutics, Inc. | $3.17B | $45.14 | 2.25% |
| XRAY | DENTSPLY SIRONA Inc. | $3.11B | $15.63 | 0.32% |
| IMVT | Immunovant, Inc. | $3.03B | $17.70 | 1.17% |
| ICUI | ICU Medical, Inc. | $2.99B | $121.66 | 0.66% |
| WRBY | Warby Parker Inc. | $2.95B | $24.29 | 1.50% |
| CRNX | Crinetics Pharmaceuticals, Inc. | $2.90B | $30.95 | 0.51% |
| LGND | Ligand Pharmaceuticals Incorporated | $2.72B | $141.12 | 1.45% |
| MIRM | Mirum Pharmaceuticals, Inc. | $2.57B | $51.95 | 0.04% |
| CPRX | Catalyst Pharmaceuticals, Inc. | $2.56B | $21.01 | 0.10% |
| RXRX | Recursion Pharmaceuticals, Inc. | $2.56B | $6.40 | 9.59% |
| RARE | Ultragenyx Pharmaceutical Inc. | $2.49B | $26.39 | 0.30% |
| OGN | Organon & Co. | $2.46B | $9.45 | 0.11% |
| APLS | Apellis Pharmaceuticals, Inc. | $2.42B | $19.28 | 0.98% |
| IBRX | ImmunityBio, Inc. | $2.37B | $2.68 | 2.55% |
| APGE | Apogee Therapeutics, Inc. | $2.33B | $39.11 | 0.51% |
| AGIO | Agios Pharmaceuticals, Inc. | $2.31B | $39.92 | 0.20% |
| WGS | GeneDx Holdings Corp. | $2.24B | $78.34 | 0.61% |
| BEAM | Beam Therapeutics Inc. | $2.11B | $21.03 | 1.35% |
| IRON | Disc Medicine, Inc. | $2.06B | $59.38 | 2.79% |
| CGON | CG Oncology, Inc. Common stock | $2.05B | $26.90 | 0.56% |
| ARWR | Arrowhead Pharmaceuticals, Inc. | $2.03B | $14.71 | 12.23% |
| HRMY | Harmony Biosciences Holdings, Inc. | $2.02B | $35.25 | 0.14% |
| DNLI | Denali Therapeutics Inc. | $2.01B | $13.83 | 1.21% |
| BLTE | Belite Bio, Inc | $1.99B | $61.30 | 0.62% |
| INDV | Indivior PLC | $1.95B | $15.60 | 2.56% |
| IDYA | IDEAYA Biosciences, Inc. | $1.91B | $21.81 | 1.02% |
| FOLD | Amicus Therapeutics, Inc. | $1.86B | $6.05 | 1.51% |
| SUPN | Supernus Pharmaceuticals, Inc. | $1.86B | $33.23 | 2.75% |
| OCUL | Ocular Therapeutix, Inc. | $1.83B | $11.52 | 1.63% |
| VCYT | Veracyte, Inc. | $1.80B | $23.03 | 2.04% |
| VCEL | Vericel Corporation | $1.79B | $35.46 | 0.34% |
| BCRX | BioCryst Pharmaceuticals, Inc. | $1.78B | $8.52 | 1.05% |
| TARS | Tarsus Pharmaceuticals, Inc. | $1.77B | $42.18 | 2.47% |
| SPRY | ARS Pharmaceuticals, Inc. | $1.75B | $17.85 | 0.39% |
| QDEL | QuidelOrtho Corporation | $1.71B | $25.30 | 0.59% |